AHAlexander Higa

Alexander Higa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alexander Higa has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Michael Solis

    Department of Dermatology and Cutaneous Surgery, University of Miami, Miller School of Medicine, Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery , RMSB Room 2089 1600 NW 10 Avenue, Miami, FL 33136 , USA

    2 shared publications
  • Stephen C. Davis

    Wound Healing Research Program, Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA

    2 shared publications
  • Allyson Mills

    Organogenesis Inc. Canton Massachusetts USA

    1 shared publication
  • Colin Simms

    Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine University of Miami Miami Florida USA

    1 shared publication
  • Jie Li

    Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine University of Miami Miami Florida USA

    1 shared publication
  • Joel Gil

    Department of Dermatology and Cutaneous Surgery, University of Miami, Miller School of Medicine, Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery , RMSB Room 2089 1600 NW 10 Avenue, Miami, FL 33136 , USA

    1 shared publication

Latest Publications

  • Open Access

    In vitro analysis of interactions between Pseudomonas aeruginosa and Candida albicans treated with silver sulfadiazine in wound infections

    by Preetha Kamath, Suchismita Paul, Jose Valdes, Joel Gil, Michael Solis, Alex Higa, Stephen C Davis

    Microorganisms tend to rely on close relationships with other species to survive. Consequently, biofilms formed by interactions of different species have been shown to delay the wound healing process. Studies suggest these mixed-population infections contribute to the development of drug resistance and inhibition of host immune response. Silver sulfadiazine (SSD) has been shown to effectively decrease the risk of infection in an open wound. Typically, these are bacterial wound infections; however, the role of fungal species needs further attention. The purpose of this in vitro study was to determine the effect of SSD on interactions between Pseudomonas aeruginosa 09-009 (PA1) or P. aeruginosa 09-010 (PA2) and Candida albicans ATTC 64550 (CA). A mixture of 4 mL of tryptic soy broth (TSB) and 100 µL of CA and/or PA1 or PA2 (∼106 log cfu/mL) inoculums were deposited into either wells or vials. The wells or vials were then sonicated (50 W for 10 s) to separate microorganisms attached to the walls. After incubation, cell counts were performed at 24 and 48 h for each microorganism using specific media. Our results show that without SSD treatment, P. aeruginosa exhibits an inhibitory effect on C. albicans. Treatment with SSD demonstrated significant reduction of P. aeruginosa; however, C. albicans persisted. This experiment demonstrates that SSD was effective in reducing the bioburden of both P. aeruginosa strains after 24 and 48 h; however, it was not as effective in reducing C. albicans. The data suggest that for polymicrobial mixed infections containing Pseudomonas spp. and C. albicans, treatment with SSD may be beneficial but does not provide adequate microorganism eradication. As such, added treatments that provide coverage for Candida infection are necessary. Additional in vivo studies are needed to obtain a better understanding of the complex interactions between these organisms.


  • Open Access

    Antimicrobial effectiveness of wound matrices containing native extracellular matrix with polyhexamethylene biguanide

    by Stephen C. Davis, Joel Gil, Michael Solis, Alexander Higa, Allyson Mills, Colin Simms, Pilar Valencia Pena, Jie Li, Vivek Raut

    A variety of wound matrix materials that are designed to help heal both acute and chronic wounds are currently available. Because wounds often encounter opportunistic microbes that can delay healing, the effectiveness of these materials is often suboptimal, resulting in delayed or compromised wound healing. The importance of reducing and controlling wound microbes is well recognised and there are several antimicrobial options available to address this unmet clinical need. This study compares the antimicrobial and wound healing capabilities, both in vivo and in vitro against methicillin‐resistant Staphylococcus aureus (MRSA) USA 300, for the following compounds: Collagen Wound Matrix‐Anti Microbial (CWM‐AM); Collagen Wound Matrix‐Anti Microbial XT (CWM‐AM XT); Antimicrobial Hydrofiber Wound Dressing (AHWD); Dermal Scaffold with Silver (DRSAg); Collagen Extracellular Matrix (CEM); Collagen Wound Matrix (CWM); Matrix Wound Dressing with Silver (MWDAg); Cadexomer Iodine Gel (CIG); Triple Antibiotic Ointment (TAO); and Antimicrobial Wound Gel (AWG). For the in vitro zone of inhibition assay, AWG and CIG had the largest diffused areas, followed by CWM‐AM and CWM‐AM XT. Furthermore, CWM‐AM, CWM‐AM XT, AWG, and CIG exhibited a persistent antimicrobial activity for up to 10 days after incubation. However, in the cytotoxicity studies performed using human fibroblasts, CWM‐AM and CWM‐AM XT had no detrimental effects in cell proliferation and viability, while AWG and CIG were cytotoxic and prohibitive for cell proliferation. Treatments were then assessed for microbiology and wound healing efficacy using an in vivo porcine deep reticular dermal wound model. CWM‐AM XT displayed the greatest in vivo antimicrobial activity against MRSA USA300 and expedited the reepithelialisation at a faster rate than other treatment groups. This study shows that a novel collagen matrix containing an antimicrobial agent can reduce the bacterial load and support healing.